CIRC Biosciences
- Employees
- 1–10
- Business Model
- B2B
- Website
- circbiosciences.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Corporate RoundAug 2025
- Rounds
- 2
About
CiRC Biosciences is a regenerative medicine company developing cellular reprogramming therapies for degenerative eye and brain diseases.
Summary
CIRC Biosciences is a Biotech company. It has raised $15.0M in total across 2 rounds, most recently a $15.0M Corporate Round round in Aug 2025. Investors include Harmony Biosciences, Paragon Biosciences and Valor Equity Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company